MedPath

Impact of Local Drug Delivery of Minocycline on the Subgingival Microbiota during Supportive Periodontal Therapy: A Pilot Study

Not Applicable
Conditions
Periodontitis
Registration Number
JPRN-UMIN000036010
Lead Sponsor
iigata University
Brief Summary

ocal administration of Periocline, a minocycline slow-release formulation, was clearly effective for not only red complex bacteria but also emerging periodontopathic bacteria. However, the duration of effect was at least 4 weeks but cannot be maintained during regular SPT interval. Although the bacterial composition returned dysbiotic at 8 weeks, % sites showing BOP was remained low at 8 weeks suggesting that bacterial composition is not inflammophilic and may be different from that at baseline.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1) use of systemic or local antimicrobials in the past 6 months 2) scaling and root planing treatment under local anesthesia for target teeth in the previous 3 months 3) subgingival mechanical debridement for target teeth in the previous 1 month 4) allergies to conventional tetracycline agents

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences of subgingival microbiota of test group and control group between before and after treatment
Secondary Outcome Measures
NameTimeMethod
1) Change in the counts of total and red complex bacteria of subgingival plaque of test group and control group between before and after treatment 2) Change in the clinical parameters of before and after treatment between test group and control group
© Copyright 2025. All Rights Reserved by MedPath